(Q34659812)

3 August 2017

title

Highly potent modulation of GABA(A) receptors by valerenic acid derivatives (English)

1 reference

3 August 2017

1 reference

ChEBI release 2020-05-28

Sascha Kopp

1

1 reference

3 August 2017

Roland Baur

2

1 reference

3 August 2017

Erwin Sigel

3

1 reference

3 August 2017

Hanns Möhler

4

1 reference

3 August 2017

Karl-Heinz Altmann

5

1 reference

3 August 2017

publication date

1 May 2010

1 reference

3 August 2017

1 reference

3 August 2017

volume

5

1 reference

3 August 2017

issue

5

1 reference

3 August 2017

page(s)

678-681

1 reference

GABAA receptors: properties and trafficking

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000062

GABA(A) receptor diversity and pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000062

GABA-based therapeutic approaches: GABAA receptor subtype functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000062

GABA-A receptors: a viable target for novel anxiolytics?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000062

GABAergic analgesia: new insights from mutant mice and subtype-selective agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000062

Analysis of GABAA receptor function and dissection of the pharmacology of benzodiazepines and general anesthetics through mouse genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000062

GABA A receptors as in vivo substrate for the anxiolytic action of valerenic acid, a major constituent of valerian root extracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000062

Valerenic acid potentiates and inhibits GABA(A) receptors: molecular mechanism and subunit specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000062

Valerian extract and valerenic acid are partial agonists of the 5-HT5a receptor in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000062

Discovery of 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide (apixaban, BMS-562247), a highly potent, selective, efficacious, and orally bioavailable inhibitor of blood [...]

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000062

The Xenopus oocyte: system for the study of functional expression and modulation of proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000062

The effect of subunit composition of rat brain GABAA receptors on channel function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000062

Forced subunit assembly in alpha1beta2gamma2 GABAA receptors. Insight into the absolute arrangement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000062

4-Dimethylamino-pyridin, ein hochwirksamer Acylierungskatalysator

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000062

inferred from DOI database lookup

7 January 2021

based on heuristic

Potent nonpeptide angiotensin II receptor antagonists. 2. 1-(Carboxybenzyl)imidazole-5-acrylic acids

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000062

inferred from DOI database lookup

7 January 2021

based on heuristic

Total synthesis of valerenic acid, a potent GABAA receptor modulator

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000062

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/CMDC.201000062

1 reference

3 August 2017

1 reference